
|Articles|November 20, 2010
Acquisition announced
Optos plc has announced its proposed acquisition of the entire issued shared capital of Opto Global Holdings for up to $14.75 million.
Advertisement
Optos plc has announced its proposed acquisition of the entire issued shared capital of Opto Global Holdings for up to $14.75 million.
This transaction will afford Optos a strong product range in glaucoma, retina, cataract & refractive treatment and diagnosis, and a global distribution network. Additionally, the company will be able to expand Opto Global's products into the US and EU markets as well as promoting its own products in the Far and Middle East, Australasia, Africa and Latin America.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Johnson & Johnson to acquire Ollin Biosciences in deal worth up to $3.3 billion
2
Q&A: What the FDA’s class-wide NAION warning on GLP-1s means for eye care
3
Dazodalibep data put Sjögren screening in focus for ophthalmologists
4
Q&A: Caroline R. Baumal, MD, from academic retina to the C-suite and back | Eichenbaum Acorns
5













